Back to search
Monogenic Obesity
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Monogenic Obesity trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Monogenic Obesity trials you may qualify forThis study is researching an experimental drug called mibavademab. The study is focused on patients with a condition called monogenic obesity. Monogenic obesity…
This observational study aims to assess the effect of once-weekly s.c. semaglutide 2.4 mg as an adjunct to a calorie-reduced diet and increased physical activit…
Genetic obesity results from changes in specific genes that affect appetite regulation, metabolism, and fat storage. Its severity and associated health issues v…
Rare genetic forms of obesity, so called monogenic obesity are linked to alteration in energy balance involving hypothalamic pathways. More than 60 genes encod…
Provide Expanded Access to REGN4461 for patients with diseases associated with deficient leptin signaling.
Non-syndromic monogenic obesity is a group of rare diseases characterized by severe and early onset obesity. Genetic characterization of these rare forms is imp…
Obesity is a frequent disease mainly caused by environmental/polygenic factors and more rarely caused by the alteration of a single gene ("monogenic obesity").…